Finance

Beta
Lists
4151:TYO
Kyowa Kirin Co Ltd
2 417,00 JP¥
-0,47%
(-11,50) 1D
12 հնս, 11:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4151...
Open
2 439 JP¥
High
2 440 JP¥
Low
2 394 JP¥
Mkt. cap
1,27 տրլն
Avg. vol.
1,54 մլն
Volume
710,60 հզր
Dividend
2,57%
Quarterly dividend
15 JP¥
Ex-dividend date
29 հնս, 2026 թ.
P/E ratio
17,35
52-wk high
2 912 JP¥
52-wk low
2 109 JP¥
EPS
139 JP¥
Shares outstanding
547,44 մլն
No. of employees
5 հզր
Open
2 439 JP¥
High
2 440 JP¥
Low
2 394 JP¥
Mkt. cap
1,27 տրլն
Avg. vol.
1,54 մլն
Volume
710,60 հզր
Dividend
2,57%
Quarterly dividend
15 JP¥
Ex-dividend date
29 հնս, 2026 թ.
P/E ratio
17,35
52-wk high
2 912 JP¥
52-wk low
2 109 JP¥
EPS
139 JP¥
Shares outstanding
547,44 մլն
No. of employees
5 հզր
News stories
From sources across the web
Profile
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and was among the 40 largest in the world by revenue in 2012. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. Wikipedia
About Kyowa Kirin Co Ltd
CEOMasashi Miyamoto
Employees5,16 հզր
Founded01 հլս, 1949 թ.
Headquarters-
Sector-
Last report
07 մյս, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
118,47 մլրդ / 117,13 մլրդ
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
125,93 մլրդ
118,80 մլրդ
147,38 մլրդ
118,47 մլրդ
Cost of goods sold
37,27 մլրդ
28,20 մլրդ
37,87 մլրդ
30,22 մլրդ
Cost of revenue
37,27 մլրդ
28,20 մլրդ
37,87 մլրդ
30,22 մլրդ
Research and development expenses
23,94 մլրդ
24,33 մլրդ
24,35 մլրդ
27,16 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40,78 մլրդ
38,72 մլրդ
31,35 մլրդ
41,07 մլրդ
Operating expense
77,03 մլրդ
63,05 մլրդ
72,15 մլրդ
71,01 մլրդ
Total operating expenses
114,30 մլրդ
91,25 մլրդ
110,02 մլրդ
101,23 մլրդ
Operating income
11,63 մլրդ
27,55 մլրդ
37,35 մլրդ
17,23 մլրդ
Other non operating income
1,19 մլրդ
-1,69 մլրդ
13,50 մլրդ
-7,71 մլրդ
EBT including unusual items
14,12 մլրդ
25,95 մլրդ
39,30 մլրդ
13,93 մլրդ
EBT excluding unusual items
14,12 մլրդ
25,95 մլրդ
51,23 մլրդ
13,93 մլրդ
Income tax expense
3,96 մլրդ
9,67 մլրդ
4,86 մլրդ
1,89 մլրդ
Effective tax rate
28,08%
37,26%
12,36%
13,59%
Other operating expenses
12,30 մլրդ
-
3,92 մլրդ
-
Net income
10,15 մլրդ
16,28 մլրդ
34,44 մլրդ
12,03 մլրդ
Net profit margin
8,06%
13,70%
23,37%
10,16%
Earnings per share
-
-
-
-
Interest and investment income
1,38 մլրդ
1,18 մլրդ
2,71 մլրդ
5,68 մլրդ
Interest expense
-2,54 մլրդ
-529,00 մլն
-28,00 մլն
-2,27 մլրդ
Net interest expenses
-1,16 մլրդ
653,00 մլն
2,68 մլրդ
3,41 մլրդ
Depreciation and amortization charges
-
-
12,54 մլրդ
-
EBITDA
17,85 մլրդ
33,97 մլրդ
44,74 մլրդ
24,88 մլրդ
Gain or loss from assets sale
506,00 մլն
-
2,77 մլրդ
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more